{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/SSME/SE0011178458",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# Dicot Pharma AB (First North Sweden: SE0011178458) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is Dicot Pharma AB, listed on First North Sweden under ticker SE0011178458, ISIN SE0011178458, LEI 549300GX132RSE4OV407. Security type, segment, sector and jurisdiction are not on the record. Listing status on the record date is listed, not halted.\n\n## The disclosure read\n\nThe record holds 36 filings in the twelve months to 2026-11-06, on 35 filing days. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-02, 4 days before the record date, and is of type Other information disclosed according to the rules of the Exchange. The exchange median cadence gap is 11.0 days across 325 issuers, the exchange median filings count is 21, and the exchange median latency is 7 days. Sector peer figures are not on the record for this market.\n\n## Auditor\n\nThe auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is off: the issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with chapter as-of date 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the issuer's investor-relations pages read.\n\n## Open research\n\nThe record holds 6 openly published research notes: Stockpicker on 2023-10-27 (two notes), Aktiespararna on 2021-10-11, Mangold Insight on 2021-03-26, Mangold Insight on 2020-10-08, and Mangold Insight on 2020-05-29.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No years are sealed for this issuer, no earliest sealed date is recorded for the market, and the live record start date is not on the record.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/SSME/SE0011178458 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.dicotpharma.com/en/investor-relations/analysis/ (open research)\n- https://mcp.se-cm-kg.ai/record/SSME/SE0011178458 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/SSME/SE0011178458",
  "coverage": {
   "count": 0,
   "houses": [],
   "pages_checked": [],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": null,
   "state": "none_found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 325,
     "median_cadence_gap_days": 11,
     "median_filings": 21,
     "median_latency_days": 7,
     "name": "First North Sweden"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual financial report": 1,
    "Changes in board/management/certified adviser/auditor/liquidity provider": 1,
    "Corporate Action": 11,
    "Decisions of general meeting": 1,
    "Financial statement release": 1,
    "Half year financial report": 1,
    "Inside information": 1,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 14,
    "Notice to general meeting": 1,
    "Other information disclosed according to the rules of the Exchange": 1,
    "Total number of voting rights and capital": 1
   },
   "cadence_median_gap_days": 5.5,
   "filing_days": 35,
   "filings": 36,
   "latency_days": 4,
   "latest": [
    {
     "category": "Other information disclosed according to the rules of the Exchange",
     "date": "2026-11-02",
     "source": "https://view.news.eu.nasdaq.com/view?id=b6387991388f0ca5aa40d19e932be5485&lang=en&src=listed",
     "title": "Nomination Committee appointed for Dicot Pharma AB",
     "type": "Other information disclosed according to the rules of the Exchange"
    },
    {
     "category": "Interim report (Q1 and Q3)",
     "date": "2026-10-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=b8896bceff8672528dbb55d23880ec460&lang=en&src=listed",
     "title": "Dicot Pharma presents interim report Q3 2026 and invites to a webcast",
     "type": "Interim report (Q1 and Q3)"
    },
    {
     "category": "Investor News",
     "date": "2026-10-26",
     "source": "https://view.news.eu.nasdaq.com/view?id=b51530ec208136e9e7cbcb05b4adf7344&lang=en&src=listed",
     "title": "Dicot Pharma receives new patent in Europe for LIB-01",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-10-13",
     "source": "https://view.news.eu.nasdaq.com/view?id=bfd383a75b775daa08091fab58645ceee&lang=en&src=listed",
     "title": "Dicot Pharma's LIB-01 attracted attention when leading experts presented at SMSNA",
     "type": "Investor News"
    },
    {
     "category": "Investor News",
     "date": "2026-10-07",
     "source": "https://view.news.eu.nasdaq.com/view?id=bf39d71fd2e67fd45e898f591167113c4&lang=en&src=listed",
     "title": "Dicot Pharma invites to an investor presentation on October 13",
     "type": "Investor News"
    }
   ],
   "latest_filing_date": "2026-11-02",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0011178458",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "First North Sweden"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0011178458"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0011178458)",
    "state": "sourced",
    "value": "549300GX132RSE4OV407"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Dicot Pharma AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0011178458"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:180510ba76c11bfe470c13a8260720b677cf11f77c1f4e3e5cecc2c8597f5726",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [
    {
     "date": "2023-10-27",
     "kind": "issuer-sponsored",
     "publisher": "Stockpicker",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.dicotpharma.com/en/investor-relations/analysis/",
     "state": "sourced",
     "title": "Uppdragsanalys 27 oktober 2023"
    },
    {
     "date": "2023-10-27",
     "kind": "issuer-sponsored",
     "publisher": "Stockpicker",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.dicotpharma.com/en/investor-relations/analysis/",
     "state": "sourced",
     "title": "Commissioned Research, October 27, 2023"
    },
    {
     "date": "2021-10-11",
     "kind": "independent",
     "publisher": "Aktiespararna",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.dicotpharma.com/en/investor-relations/analysis/",
     "state": "sourced",
     "title": "Marknad med blockbusterpotential"
    },
    {
     "date": "2021-03-26",
     "kind": "issuer-sponsored",
     "publisher": "Mangold Insight",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.dicotpharma.com/en/investor-relations/analysis/",
     "state": "sourced",
     "title": "Dicot - Mot kliniska studier i högt tempo"
    },
    {
     "date": "2020-10-08",
     "kind": "issuer-sponsored",
     "publisher": "Mangold Insight",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.dicotpharma.com/en/investor-relations/analysis/",
     "state": "sourced",
     "title": "Dicot - Framsteg för Viagrautmanare"
    },
    {
     "date": "2020-05-29",
     "kind": "issuer-sponsored",
     "publisher": "Mangold Insight",
     "read_by": "the note's own page, fetched by this rail",
     "read_date": "2026-11-12",
     "source": "https://www.dicotpharma.com/en/investor-relations/analysis/",
     "state": "sourced",
     "title": "Dicot - Erektion som investering"
    }
   ],
   "state": "found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/SSME/SE0011178458",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:180510ba76c11bfe470c13a8260720b677cf11f77c1f4e3e5cecc2c8597f5726",
 "path": "/se/SSME/SE0011178458",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is Dicot Pharma AB, listed on First North Sweden under ticker SE0011178458, ISIN SE0011178458, LEI 549300GX132RSE4OV407. Security type, segment, sector and jurisdiction are not on the record. Listing status on the record date is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 36 filings in the twelve months to 2026-11-06, on 35 filing days. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-02, 4 days before the record date, and is of type Other information disclosed according to the rules of the Exchange. The exchange median cadence gap is 11.0 days across 325 issuers, the exchange median filings count is 21, and the exchange median latency is 7 days. Sector peer figures are not on the record for this market.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record and its location are not on the record. Auditor changes are not on the record, as this register has no lifecycle type map yet.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this register has no lifecycle type map yet. The halt flag is off: the issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, with chapter as-of date 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "No research houses were found on the issuer's investor-relations pages read.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "The record holds 6 openly published research notes: Stockpicker on 2023-10-27 (two notes), Aktiespararna on 2021-10-11, Mangold Insight on 2021-03-26, Mangold Insight on 2020-10-08, and Mangold Insight on 2020-05-29.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No years are sealed for this issuer, no earliest sealed date is recorded for the market, and the live record start date is not on the record.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/SSME/SE0011178458"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "open research",
   "source": "https://www.dicotpharma.com/en/investor-relations/analysis/"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/SSME/SE0011178458"
  }
 ],
 "title": "Dicot Pharma AB (SE0011178458) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}